Kaynes Technology drops 25% in 3 days after weak Q4
Kaynes Technology India Ltd
KAYNES
Ask AI
What triggered the sudden selloff
Kaynes Technology India shares saw a sharp, three-day slide after the company reported a weaker-than-expected March quarter and brokerages turned more cautious. The move intensified after Elara Securities cut its rating to ‘Accumulate’, and reports said JPMorgan also downgraded the stock while lowering its target price. Investors also reacted to concerns raised by Kotak Institutional Equities around inconsistencies in the EMS player’s related-party disclosures. The episode put the spotlight back on execution, margins, and working capital management.
Where the stock traded during the fall
The stock’s reported levels during early July showed a wide range as selling pressure built. Kaynes Technology’s share price was reported at Rs 3,158.50 as on 02 Jul, 2026 (03:58 PM IST). Another data point in the same context showed the day’s low at Rs 3,271.60 and the day’s high at Rs 3,397.80. Separately, the share price of KAYNES was cited at Rs 3,359.20 as on 6th July 2026. The stock was also reported to have fallen to Rs 3,760.10 on the BSE following the earnings-led brokerage caution.
Q4 numbers that disappointed the Street
The March quarter outcome was described as weaker than expected on multiple fronts. Profit fell 22% year-on-year, even as revenue grew 26% year-on-year, and the revenue outcome reportedly missed internal targets. The company also missed key FY26 guidance metrics mentioned in coverage, including revenue and operating cash flow. Alongside the headline numbers, commentary pointed to weaker balance sheet metrics as part of the negative reaction.
Brokerage actions and the key concerns cited
The biggest immediate trigger highlighted in the coverage was the downgrade by JPMorgan Chase & Co., which raised concerns around valuation, margin sustainability, and near-term growth expectations. JP Morgan, Nuvama and CLSA were among brokerages that cut targets, citing execution concerns, margin pressure, and weak near-term visibility. Elara’s downgrade to ‘Accumulate’ added to the cautious tone. At the same time, the selloff gained fuel from questions around disclosures after Kotak Institutional Equities flagged inconsistencies in related-party disclosures.
Management guidance, revenue ambitions, and FY targets
Despite the negative reaction to Q4, the company reiterated optimism on growth traction across verticals. In earlier guidance referenced in the coverage, the company said it expected to exceed an estimated revenue target of INR 3,000 crore, along with an EBITDA margin target of 15%. Separately, revised FY26 revenue guidance was cited at INR 4,100 crore. The order book was reported at INR 9,072 crore, described as a 67% jump from INR 5,422 crore a year ago. Management commentary also pointed to delayed railway order dispatches as a key culprit in the recent softness.
Bottlenecks and operational friction in focus
Apart from execution, the coverage highlighted bottlenecks affecting timelines. One stated factor was geopolitical friction, with references to West Asia conflict leading to supply-chain delays and pushing out the timing of some projects. This was presented as a practical driver of slippage rather than a change in long-term demand. However, the near-term effect was visible in investor focus on delivery schedules and cash conversion.
OSAT plant and new verticals: what the company expects
While FY27 growth targets were said to be lowered in the coverage, the company anticipates future revenue contributions from its OSAT plant. The business mix was described as being led by Electronic Manufacturing Services (EMS), alongside newer growth verticals in OSAT (semiconductor assembly and testing) and High-Density Interconnect PCBs (HDI PCBs). The OSAT narrative also appeared in market commentary that the company had received FSA approval for the Sanand OSAT facility.
Sector backdrop: electronics manufacturing policy tailwinds
The selloff in Kaynes came amid a broader correction in electronics manufacturing services (EMS) stocks after a period of strong gains. The coverage referenced Budget 2026 raising the Electronics Component Manufacturing Scheme outlay to INR 40,000 crore, which had supported sentiment for Dixon Technologies, Kaynes Technology, PG Electroplast and others. It also noted that the sector’s next phase of recovery would be linked to proof of improved profitability and policy triggers such as mobile PLI extension and ISM 2.0 rollout, as cited in brokerage commentary.
Key numbers at a glance
Market impact: what changed for investors
The immediate market impact was a reset in expectations around execution and the pace of growth after the quarter’s miss and the commentary about working capital and cash flows. Investors also had to factor in heightened scrutiny following the disclosure-related concerns raised by Kotak. In price terms, the stock’s three-day fall of nearly 25% reflected a sharp de-rating over near-term visibility. Longer-term debate remained anchored on whether order book strength and OSAT optionality can offset near-term volatility.
Analysis: why this episode matters
Two threads dominated the reaction: trust in reported numbers and confidence in delivery timelines. When a stock already carries elevated expectations, a guidance miss or weaker operating cash flow can lead to outsized price moves, especially when broker downgrades arrive at the same time. The other structural point is that Kaynes sits within a policy-supported electronics manufacturing push, where incentives and supply-chain shifts have driven growth but also increased investor sensitivity to execution. The next set of disclosures, working capital trend, and clarity on OSAT ramp will likely be central to how the market reassesses the stock.
Conclusion
Kaynes Technology’s sharp decline followed a weak Q4, guidance and cash-flow misses noted in coverage, and a wave of broker caution led by downgrades and questions around disclosures. At the same time, management has reiterated growth ambitions backed by a reported INR 9,072 crore order book and cited FY26 revenue guidance of INR 4,100 crore. Near-term attention is likely to stay on execution timelines, margin trajectory, and any further updates on OSAT revenue contribution as the company moves into the next financial year.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker